CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2012--
ARIAD
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
webcast its presentation at the Cowen and Company 32nd Annual
Health Care Conference in Boston. Harvey J. Berger, M.D., chairman and
chief executive officer, will provide an overview of the Company’s
business on Tuesday, March 6, 2012 at 9:20 a.m. (ET).
The ARIAD presentation at the Cowen and Company 32nd Annual
Health Care Conference will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at http://www.ariad.com/investor.
A replay of the webcast presentation will also be available and archived
on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD’s approach to
structure-based drug design has led to three internally discovered,
molecularly targeted product candidates for drug-resistant and
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia, soft tissue and bone sarcomas and non-small cell lung cancer.
For additional information, visit http://www.ariad.com.
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
For Investors
Maria E.
Cantor, 617-621-2208
Maria.cantor@ariad.com
or
For
Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com
